Feature | November 09, 2006 | Cristen C. Bolan

RSNA 2006 Stages the Changing Role of Radiology

As if RSNA wasn’t big enough, expect it to be even bigger this year. As the scope of radiology widens, so does the category of radiology subspecialties. RSNA 2006 has designed its program to reflect this change, adding to its curriculum important research across multiple radiology subspecialties – cardiac radiology, emergency radiology, neuroradiology, vascular and interventional radiology, breast/mammography, gastrointestinal radiology and genitourinary radiology, to name just a few. In light of molecular imaging’s tremendous potential for eradicating diseases — by revealing the early presence or likelihood of disease — molecular imaging will make its debut as a subspecialty area at this year’s RSNA.
Take note that the growing number of subspecialties is the precursor to the convergence of certain medical disciplines – principally radiology, pathology and cardiology – and manufacturers are poised to deliver new solutions for these anticipated developments.
Vendor participants at RSNA are also eager to show off their new product releases, many of which are inspired by growth areas in radiology, such as PET/CT and SPECT/CT hybrids, multislice CT, high channel MR, cardiac CT and MR, artificial intelligence and EMR/PACS solutions. Get a sneak peak at these in our extensive RSNA Preview in this issue.
The RSNA Scientific Program Committee is enthusiastic about this year’s presentations, which will introduce new approaches to fusion, perfusion/diffusion, multiplanar and dual energy imaging techniques, advancements in multislice CT, the explosion of cardiac CT, as well as novel CAD applications.
Imaging Technology News is looking forward to hitting the RSNA floor and seeing new technology in action. But we are especially interested in meeting our readers in person. So please stop by to see us at Booth #3915, or e-mail me to arrange a meeting in advance, [email protected].
See you at the show!

Related Content

GE Healthcare Recalls Millennium Nuclear Medicine Systems
News | Nuclear Imaging | November 15, 2018
GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident in which the the top...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
University of Missouri Research Reactor First U.S. I-131 Supplier in 30 Years

MURR is the only supplier of I 131 in the United States and the first U.S. supplier since the 1980s. Image courtesy of University of Missouri

News | Radiopharmaceuticals and Tracers | November 13, 2018
The University of Missouri Research Reactor (MURR) recently shipped its first batch of Iodine-131 (I-131), a...
MEDraysintell Projects Increasing Mergers and Acquisitions in Nuclear Medicine
News | Nuclear Imaging | November 07, 2018
With the recent announcement by Novartis to acquire Endocyte , interest from the conventional pharmaceutical industry...
A PET/CT head and neck cancer scan.

A PET/CT head and neck cancer scan.

Feature | Nuclear Imaging | November 05, 2018 | By Sabyasachi Ghosh
“Experimental validation implemented in real-life situations and not theoretical claims exaggerating small advantages
PET Imaging Offers New Possibilities in Chronic Liver Disease Management

Hepatic 18F-FDG, 18F-FAC, and 18F-DFA accumulation are affected in a mouse model of autoimmune hepatitis. (A) Histochemical and immunohistochemical analyses of liver sections from vehicle- and ConA-treated mice. Scale bars represent 50 microns. Transverse PET/CT images (B) and quantification (C) of vehicle- and ConA-treated mice injected with 18F-FDG, 18F-FAC, and 18FDFA. Livers are outlined in a white dotted line. Quantification represents radiotracer accumulation in the liver normalized to a background organ. Image courtesy of Salas J.R., Chen B.Y., Wong A., et al.

News | PET Imaging | October 24, 2018
While liver biopsies are powerful and reliable, they are also invasive, painful, limited and subject to complications....
CORAR Supports Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2018
News | Radiopharmaceuticals and Tracers | October 12, 2018
October 12, 2018 — The Council on Radionuclides and Radiopharmaceuticals Inc.
Huntsman Cancer Institute Installs First Preclinical nanoScan 3T PET/MRI in U.S.
News | PET-MRI | October 10, 2018
The Center for Quantitative Cancer Imaging at Huntsman Cancer Institute (HCI) at the University of Utah in Salt Lake...